It’s an area of the east of St. John’s that has been a hotbed for developers. Plans for the former Bally Haly golf course ...

Inhibikase Therapeutics, Inc. (Nasdaq: IKT) ("Inhibikase” or "Company”), a clinical-stage pharmaceutical company developing ...

Contineum Therapeutics’ M1 receptor antagonist has failed to move the needle in a phase 2 vision test for patients with a common form of multiple sclerosis. | Contineum Therapeutics’ M1 receptor ...

Ribomic, Inc. ( ($JP:4591) ) has issued an update. RIBOMIC, Inc. has announced promising results from a Phase 2 clinical trial of their drug ...

An update from Syntara Limited ( ($AU:SNT) ) is now available. Syntara Limited has announced the commencement of the MDS05/D3 MESSAGE Phase 2 ...

Nurix Therapeutics is trimming its workforce not long after launching a pivotal phase 2 trial for its lead cancer asset. | ...

COLUMN. The US president described the UN Security Council's vote on phase II of his peace plan as the dawn 'a golden age for ...

Discover six obesity deals made so far in 2025, with dealmaking activity in the field being largely dominated by big pharma ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

Residents will have additional opportunities to provide input as the project continues through the approval process.

Trial participants who used eloralintide, a new weight loss medication that, instead of focusing on the hormone GLP-1, ...

Zymeworks advances with strong Phase III Ziihera data, royalty-driven growth, solid cash, updated buy and sell levels. See ...